Company Filing History:
Years Active: 2001-2009
Title: Eng Mong Lim: Innovator in Antibody Research
Introduction
Eng Mong Lim is a notable inventor based in Paris, France. He has made significant contributions to the field of antibody research, holding a total of 3 patents. His work focuses on the development of purified antibodies that have important applications in identifying Mycobacteria.
Latest Patents
Eng Mong Lim's latest patents include innovative methods for producing purified antibodies that specifically bind to the ERP protein. One embodiment of his invention provides a purified antibody that interacts with a polypeptide comprising SEQ ID NO: 39 or SEQ ID NO: 41. The polypeptide may have a theoretical molecular weight of approximately 28 kDa, while in other instances, it has an observed molecular weight of about 36 kDa, as determined by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). The purified antibodies can be either monoclonal or polyclonal and have various applications, including the identification of Mycobacteria.
Career Highlights
Eng Mong Lim is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work has been instrumental in advancing the understanding of antibody interactions and their potential uses in medical applications.
Collaborations
Eng Mong Lim collaborates with esteemed colleagues, including Brigitte Gicquel and Denis Portnoi, who contribute to his research endeavors.
Conclusion
Eng Mong Lim's innovative work in antibody research has led to significant advancements in the field, showcasing his expertise and dedication to scientific discovery. His contributions continue to impact the understanding of Mycobacteria and the development of therapeutic applications.